Topic Archives: Ligand Pharmaceuticals (LGND)

Smallcap Discoveries says “Big Pharma NEEDS this company to cure cancer” and asks, “What if you could live to 200?”

I’ve only written once about the Smallcap Discoveries service, so when several readers sent in questions about its “what if you could live to 200?” pitch, I decided to dig in a little. Longevity is a frequent focus of the alternative health crowd, promising life extension to those most obviously interested in the topic (who […]

Friday File: Two Sell/Buy Simplifications in Mining, plus more Buffett, a Dating Trade, and thoughts on a dozen other holdings

We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so prepare for a lot of quick updates…. Medical Properties Trust (MPW) reported another quarter of ho-hum… pretty much met the forecasts, […]

Cisco, Chang & Charlie

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here. Enjoy!] Do you have quirky, enigmatic notions that hang with you? Douglas Hofstadter, writing in Godel, Escher and Bach: […]

Comments

  • Avatar

    Since his buying advice the stock dropped 50%,you better short the stocks he recs ,never pay hundreds or thousends $ for...

  • Avatar

    Travis, Does LGND have to follow the royalty model? SAND turned its fortunes when it broke the mold. Perhaps LGND is go...

  • Avatar

    Travis, Does tonight's news from LGND change the assessment you made when closing position? My quick take is that expec...

  • Travis Johnson, Stock Gumshoe

    Ligand Pharmaceuticals (LGND) announced a bombshell today, they're selling Promacta to Novartis and Royalty Pharma for $...

  • Avatar

    Based upon other posts, it's Ligand Pharmaceuticals (LGND). They're down more than 50%...

  • Avatar

    Thank you Travis. Yes, I noticed LGND went down 50% in the past couple months. It's either a bad sign of things to come ...

  • Avatar

    Bought into LGND on Christmas Eve, and if it wasn't for occasionally reading about your strategies including stop losses...

  • Avatar

    Travis: Kudos for selling part of the position when things looked good and for sticking to stop loss discipline for the ...

  • Travis Johnson, Stock Gumshoe

    I watch stop losses for all my stocks, but don't follow them mechanically -- I take them far more seriously for momentum...

  • Travis Johnson, Stock Gumshoe

    The lawsuits like that will crop up everywhere, though probably won’t mean anything — that’s just lawyers trying t...

  • Travis Johnson, Stock Gumshoe

    I had a stop loss order in for Ligand as sort of a "disaster" price if the narrative really falls apart, given my assess...

  • Travis Johnson, Stock Gumshoe

    Just ran into this comment when looking for some info about Ligand that I had written -- not trying to pick on the Doc, ...

  • Travis Johnson, Stock Gumshoe

    Haven't written about Lichtenfeld's tease, but someone sent it to me today and it's clearly Ligand being touted as this ...

  • Dr. KSS MD PhD

    Dan: I am a little rattled because I had been intending to present Madrigal as a long idea of the month for December, an...

  • Dr. KSS MD PhD

    Dova Pharmaceuticals will be debuting by IPO shortly, and this one's interesting. It's a play on avatrombopag, a second-...

  • Avatar

    ddman92129, In my humble opinion if you simply must be in biotech, buy with the money you can afford to lose $IBB and ...

  • Avatar

    I took the "Bait" and subscribed to Riggs' "Small Cap Rocket" newsletter, but only because it came with a grantee that i...

  • Travis Johnson, Stock Gumshoe

    Not 8 stocks, 8 drugs. As to whether it's LGND, there's no room for doubt given those clues: either he's recommending L...

  • Avatar

    Thanks for this. So, knowing the names of the 8 stocks themselves doesn't really matter. Now is there anyone who did j...

  • Avatar

    LGND for almost 8 points so far from 115 to 123 although it has basically just beat the IBB by a few percent....

  • sogiam

    $LGND also covered in this February article: http://www.stockgumshoe.com/2016/02/february-idea-of-the-month/ Best2You-...

  • Avatar

    Travis, I can't remember what you ended up doing with $LGND, but noticed it is now up to around 100 again. Remember a ...

  • Avatar

    Dang Travis. Have you seen Ligand $LGND lately? Doubled since Feb. They report earnings for 2Q after market closes today...

  • Avatar

    Thanks Travis, When I see a lousy looking chart and large short interest it reminds me of LGND and look what that chart...

  • Travis Johnson, Stock Gumshoe

    I mean that if results are better than expected and the stock rises, there are enough short sellers that it's possible t...

  • Travis Johnson, Stock Gumshoe
  • Travis Johnson, Stock Gumshoe

    The last time I wrote about Ligand, following that short analysis, was here: http://www.stockgumshoe.com/2014/06/points-...

  • Avatar

    Travis, What do you make of this firm's analysis of Ligand? See below. http://www.valuewalk.com/2014/06/lemelson-lig...

  • Avatar

    Dr. KSS; I wonder if you have any comment on LGND. It is a stock that Travis and I own, as likely others, which took a ...

  • Avatar

    Robert- you are correct on SVA. Dead money for months now and will likely go lower in the near future. LGND on the other...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch